These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27016705)

  • 1. Rosuvastatin may stabilize vulnerable carotid plaques and reduce carotid intima media thickness in patients with hyperlipidemia.
    Liu T; Meng XY; Li T; Zhang DY; Zhou YH; Han QF; Wang LH; Wu L; Yao HC
    Int J Cardiol; 2016 Jun; 212():20-1. PubMed ID: 27016705
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label).
    Braamskamp MJAM; Langslet G; McCrindle BW; Cassiman D; Francis GA; Gagne C; Gaudet D; Morrison KM; Wiegman A; Turner T; Miller E; Kusters DM; Raichlen JS; Martin PD; Stein EA; Kastelein JJP; Hutten BA
    Circulation; 2017 Jul; 136(4):359-366. PubMed ID: 28592434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.
    Lind L; Peters SA; den Ruijter HM; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Bots ML;
    J Am Soc Echocardiogr; 2012 Oct; 25(10):1120-1127.e1. PubMed ID: 22884641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.
    Crouse JR; Bots ML; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Raichlen JS;
    Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):223-9. PubMed ID: 20038840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.
    Bots ML; Palmer MK; Dogan S; Plantinga Y; Raichlen JS; Evans GW; O'Leary DH; Grobbee DE; Crouse JR;
    J Intern Med; 2009 Jun; 265(6):698-707. PubMed ID: 19298496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease.
    Riccioni G; Cipollone F; Santovito D; Scotti L; D'Orazio N; Mezzetti A; Bucciarelli T
    Expert Opin Pharmacother; 2011 Dec; 12(17):2599-604. PubMed ID: 21999752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperlipidaemia presenting as palmoplantar pain.
    Anthony EP; Lichtblau BJ; McCormack C
    Australas J Dermatol; 2018 Aug; 59(3):e213-e214. PubMed ID: 28924996
    [No Abstract]   [Full Text] [Related]  

  • 8. [Impact on the carotid intima-medial thickness and safety of rosuvastatin in Chinese patients with carotid atherosclerosis: a meta-analysis].
    Feng X; Zhang J; Liu M; Li X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Mar; 42(3):247-53. PubMed ID: 24831484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short Communication: The Effect of Rosuvastatin on Vascular Disease Differs by Smoking Status in Treated HIV Infection.
    Hileman CO; McComsey GA
    AIDS Res Hum Retroviruses; 2018 Mar; 34(3):282-285. PubMed ID: 28974102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis.
    Liu Z; Zhao Y; Wei F; Ye L; Lu F; Zhang H; Diao Y; Song H; Qi Z
    Atherosclerosis; 2014 Mar; 233(1):291-9. PubMed ID: 24495792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study: Rationale and Trial Protocol.
    Toyoda K; Minematsu K; Yasaka M; Nagai Y; Hosomi N; Origasa H; Kitagawa K; Uchiyama S; Koga M; Matsumoto M;
    J Stroke Cerebrovasc Dis; 2017 Mar; 26(3):595-599. PubMed ID: 28010953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris.
    Held C; Hjemdahl P; Eriksson SV; Björkander I; Forslund L; Rehnqvist N
    Eur Heart J; 2001 Jan; 22(1):62-72. PubMed ID: 11133211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring carotid artery intima-media thickness: simplicity versus complexity?
    Polak JF; Pencina MJ
    J Am Soc Echocardiogr; 2012 Jan; 25(1):101-4. PubMed ID: 22183023
    [No Abstract]   [Full Text] [Related]  

  • 14. Thromboxane prostaglandin receptor antagonist and carotid atherosclerosis progression in patients with cerebrovascular disease of ischemic origin: a randomized controlled trial.
    Bots ML; Ford I; Lloyd SM; Laurent S; Touboul PJ; Hennerici MG;
    Stroke; 2014 Aug; 45(8):2348-53. PubMed ID: 25070960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of carotid artery intima media thickness assessment on cardiovascular risk stratification in hyperlipidemic Korean adults with diabetes: the ALTO study.
    Hong EG; Ohn JH; Lee SJ; Kwon HS; Kim SG; Kim DJ; Kim DS
    BMC Cardiovasc Disord; 2015 Oct; 15():114. PubMed ID: 26438201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
    Calza L; Manfredi R; Colangeli V; Trapani FF; Salvadori C; Magistrelli E; Danese I; Verucchi G; Serra C; Viale P
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):547-56. PubMed ID: 23098891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.
    Peters SA; den Ruijter HM; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Bots ML;
    J Am Soc Echocardiogr; 2012 Jan; 25(1):91-100. PubMed ID: 21982737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical atherosclerosis: evolving role of carotid intima-media thickness.
    Mookadam F; Moustafa SE; Lester SJ; Warsame T
    Prev Cardiol; 2010; 13(4):186-97. PubMed ID: 20860643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis.
    Kim HJ; Kim MJ; Lee CK; Hong YH
    J Korean Med Sci; 2015 Nov; 30(11):1589-96. PubMed ID: 26539002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
    Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
    JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.